Participant flow14

How many started, completed or left each group, period by period.

1 to 14 of 14

Period	Milestone	Group	Participants
ITT Analysis	STARTED	Gemcitabine & Cisplatin	120
ITT Analysis	STARTED	Dose Dense MVAC	117
ITT Analysis	COMPLETED	Gemcitabine & Cisplatin	115
ITT Analysis	COMPLETED	Dose Dense MVAC	112
ITT Analysis	NOT COMPLETED	Gemcitabine & Cisplatin	5
ITT Analysis	NOT COMPLETED	Dose Dense MVAC	5
Primary COXEN Analysis	STARTED	Gemcitabine & Cisplatin	115
Primary COXEN Analysis	STARTED	Dose Dense MVAC	112
Primary COXEN Analysis	Participants Excluded From Primary COXEN Analysis	Gemcitabine & Cisplatin	33
Primary COXEN Analysis	Participants Excluded From Primary COXEN Analysis	Dose Dense MVAC	27
Primary COXEN Analysis	COMPLETED	Gemcitabine & Cisplatin	82
Primary COXEN Analysis	COMPLETED	Dose Dense MVAC	85
Primary COXEN Analysis	NOT COMPLETED	Gemcitabine & Cisplatin	33
Primary COXEN Analysis	NOT COMPLETED	Dose Dense MVAC	27

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT02177695/flow